Janssen Pharmaceuticals Inc. and parent company Johnson & Johnson reached a $181 million settlement with 36 states and the District of Columbia over charges of marketing Risperdal, Risperdal Consta, Risperdal M-Tab and Invega for non-FDA approved uses Risperdal, is a drug used to treat schizophrenia among other mental illnesses. Janssen is accused of [...]
